Healthcare Services Group (HCSG) Q1 2026 earnings summary

Executive summary

• Q1 2026 revenue grew 3.4% year-over-year to $462.8 million, driven by new client wins, high retention, and contractual price increases.

• Net income increased 51.3% to $26.1 million, with diluted EPS of $0.37, reflecting strong operational performance.

• Cash flow from operations was $43.7 million; adjusted for payroll accrual, $23.4 million.

• $24 million was returned to shareholders via share repurchases in Q1 under the new 2026 Repurchase Plan.

• Environmental Services and Dietary segments contributed 45% and 55% of revenues, respectively.

Financial highlights

• Operating income rose to $34.5 million, up 44.6% year-over-year.

• Adjusted EBITDA reached $38.9 million (8.4% of revenue), up from $29.3 million and 6.5% a year ago.

• Cost of services was $386.9 million (83.6% of revenue), below the 86% target due to efficiencies.

• SG&A was $42 million; adjusted SG&A was $43.6 million (9.4% of revenue).

• Cash and marketable securities at quarter-end: $214.6 million.

Outlook and guidance

• Q2 revenue expected in the $465–$475 million range, with sequential growth in H2 over H1.

• Full-year 2026 guidance targets mid-single-digit revenue growth, with effective tax rate expected at ~25%.

• Cost of services expected to normalize to 86% of revenue for the remainder of the year.

• SG&A targeted at 9.5–10.5% of revenue short-term, with a long-term goal of 8.5–9.5%.

• Capital expenditures for 2026 estimated at $5.0–$7.0 million, with $1.4 million spent through Q1.